Addanki P Kumar

7PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 17, 2023
Phagocytosis-initiated tumor hybrid cells acquire a c-Myc-mediated quasi-polarization state for immunoevasion and distant dissemination.

Chih-Wei Chou, Chia-Nung Hung, Cheryl Hsiang-Ling Chiu

|Aug 05, 2022
Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching.

Chen Chen, Shujie Zhao, Xiangru Zhao

|Apr 22, 2022
SIRT1 inhibition-induced senescence as a strategy to prevent prostate cancer progression.

Shih-Bo Huang, Paul Rivas, Xiaoyu Yang

|Mar 06, 2021
Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer.

Izhar Singh Batth, Shih-Bo Huang, Michelle Villarreal

|Mar 13, 2019
Receptor tyrosine kinase recepteur d'origine nantais as predictive marker for aggressive prostate cancer in African Americans.

Roble G Bedolla, Dimpy P Shah, Shih-Bo Huang

|Jul 25, 2018
BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions.

Huiyoung Yun, Roble Bedolla, Aaron Horning

Pageof 2

Frequent Collaborators

2 joint publications

Rita Ghosh

2 joint publications

Shih-Bo Huang

2 joint publications

Pawel Osmulski

1 joint publications

Huiyoung Yun